CDR-Life
Rouven Bingel-Erlenmeyer is the Chief Technical Development Officer at CDR-Life. Previously, Rouven was Global Lead Drug Substance Development Office Scientific Standards & Integration at Novartis.
Rouven earned a Ph.D. in Structural Biology, Protein Chemistry, Biophysics from ETH Zürich in 2007.
This person is not in any offices
CDR-Life
With access to a reservoir of unexploited intracellular cancer targets, CDR-Life is advancing a growing pipeline of highly tumor-selective immunotherapies.